Brain tumor stem cells are a rare population of stem-like cells in gliomas that may be responsible for tumor growth, recurrence and resistance, implying that targeting these cells may improve ...
Her research interests are focused on molecular biology of cancer and translational research. With a particular interested in malignant gliomas, glioma stem cells, and tumor immunology. Pauliina's ...
SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor ...
Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotechnology company advancing targeted antitumor virotherapies, will host an invest ...